U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

National Research Council (US) Committee on Laboratory Security and Personnel Reliability Assurance Systems for Laboratories Conducting Research on Biological Select Agents and Toxins. Responsible Research with Biological Select Agents and Toxins. Washington (DC): National Academies Press (US); 2009.

Cover of Responsible Research with Biological Select Agents and Toxins

Responsible Research with Biological Select Agents and Toxins.

Show details

References

  1. AAAS (American Association for the Advancement of Science). Professional and Graduate-Level Programs on Dual Use Research and Biosecurity for Scientists Working in the Biological Sciences: Workshop Report. Washington, DC: AAAS; 2008. Available at < http://cstsp​.aaas.org​/files/AAAS_workshop​_report_education_of​_dual_use_life_science_research.pdf>.
  2. AAAS. Biological Safety Training Programs as a Component of Personnel Reliability: Workshop Report. Washington, DC: AAAS; 2009. Available at < http://cstsp​.aaas.org​/files/AAAS%20Biosafety%20report.pdf>.
  3. ABSA (American Biological Safety Association). ABSA Comments to the Working Group on Strengthening the Biosecurity of the United States Following the Public Meeting; May 13–14, 2009; 2009. Available at < http://www​.absa.org/pdf​/090530ABSAcommentsBWG.pdf>.
  4. Altman Sidney, Bassler Bonnie L, Beckwith Jon, Belfort Marlene, Berg Howard C, Bloom Barry, Brenchley Jean E, Campbell Allan, Collier R John, Connell Nancy, Cozzarelli Nicholas R, Craig Nancy L, Darst Seth, Ebright Richard H, Elledge Stephen J, Falkow Stanley, Galan Jorge E, Gottesman Max, Gourse Richard, Grindley Nigel DF, Gross Carol A, Grossman Alan, Hochschild Ann, Howe Martha, Hurwitz Jerard, Isberg Ralph R, Kaplan Samuel, Kornberg Arthur, Kustu Sydney G, Landick Robert C, Landy Arthur, Levy Stuart B, Losick Richard, Long Sharon R, Maloy Stanley R, Mekalanos John J, Neidhardt Frederick C, Pace Norman R, Ptashne Mark, Roberts Jeffrey W, Roth John R, Rothman-Denes Lucia B, Salyers Abigail, Schaechter Moselio, Shapiro Lucy, Silhavy Thomas J, Simon Melvin I, Walker Graham, Yanofsky Charles, Zinder Norton. An open letter to Elias Zerhouni. Science. 2005 March 4;307(5714):1409–1410. [PubMed: 15746409]
  5. Atlas Ronald M. Testimony before the Commerce Committee’s Subcommittee on Oversight & Investigations’ Hearing on Assessing the Adequacy of Federal Law Relating to Dangerous Biological Agents. May, 1999. Statement of American Society for Microbiology Task Force on Biological Weapons Control Co-Chair Dr. Ronald M. Atlas.
  6. Auchincloss Hugh. Testimony before the U.S. House of Representatives Committee on Energy and Commerce, Subcommittee on Oversight and Investigations. Oct 4, 2007. Protecting the Public Health: The Importance of NIH Biodefense Research Infrastructure.
  7. Berry Christopher M, Sackett Paul R, Wiemann Shelly. A review of recent developments in integrity test research. Personnel Psychology. 2007;60:271–301.
  8. Besser Richard E. Testimony before the subcommittee on Oversight and Investigations, Committee on Energy and Commerce, U.S. House of Representatives. Oct 4, 2007. Oversight of Select Agents by the Centers for Disease Control and Prevention.
  9. Blaisdell MG Franklin J. Statement to the U.S. Senate Arms Service Strategic Subcommittee. Dec 13, 2001. Nuclear Weapons Security.
  10. Borum Randy. Psychology of Terrorism. Tampa: University of South Florida; 2004.
  11. Brant David, Gelles Michael G. Discussion Paper on Insider Threat Assessments: Insight into Developing a Secure Workforce, Identifying Current Risks, and Developing Mitigation Strategies (draft). Deloitte Consulting. 2009
  12. Burnett LouAnn.Presentation to the Committee; June 29. 2009.
  13. Burrelli David F. “Don’t Ask, Don’t Tell:” The Law and Military Policy on Same-Sex Behavior. Washington, DC: Congressional Research Service; 2009.
  14. Butcher James N, Ones Deniz S, Cullen Michael. Personnel screening with the MMPI-2. In: Butcher James N., editor. MMPI-2: A Practitioner’s Guide. Washington, DC: American Psychological Association; 2006. pp. 381–406.
  15. Carus W Seth. Working Paper from the Center for Nonproliferation Research. Washington, DC: National Defense University; 2001. Bioterrorism and Biocrimes: The Illicit Use of Biological Agents Since 1900 (February 2001 revision).
  16. Cascio Wayne F. Managing Human Resources: Productivity, Quality of Work Life, Profits. 8th ed. New York: McGraw-Hill; 2009.
  17. CDC (Centers for Disease Control and Prevention). Laboratory security and emergency response guidance for laboratories working with select agents. Morbidity and Mortality Weekly Report. 2002 December 6;51(RR-19):1–6. [PubMed: 12515340]
  18. CDC. Facts about the Laboratory Response Network. 2009. Available at < http://www​.bt.cdc.gov/lrn/factsheet.asp>.
  19. CDC/APHIS (CDC/Animal and Plant Health Inspection Service). Select Agents and Toxins: Security Information Document. Atlanta, GA, and Riverdale, MD: CDC and APHIS; 2007. Available at < http://www​.selectagents​.gov/resources/Security​%20Information%20Document.pdf>.
  20. CDC/NIH (CDC/National Institutes of Health). Biosafety in Microbiological and Biomedical Laboratories. 5th ed. Chosewood L Casey, Wilson Deborah E., editors. Washington, DC: U.S. Government Printing Office; 2007.
  21. CEN (European Committee for Standardization). International Laboratory Biorisk Management Standard. Brussels: CEN; 2008. CWA 15793.
  22. Concept Systems Inc. RCE Program Interim Evaluation: Report on the First Five Years of the Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) Program. Bethesda, MD: National Institute of Allergy and Infectious Diseases, Division of Microbial and Infectious Diseases; 2008.
  23. Crenshaw Martha. The causes of terrorism. Comparative Politics. 1981;13(4):379–399.
  24. Crowley M Colleen.Presentation to the Committee; August 11. 2009.
  25. Cullen Michael J, Ones Deniz S, Viswesvaran Chockalingam, Drees Shelly, Langkamp Kathryn.A Meta-Analysis of the MMPI and Police Officer Performance. In: Spillberg S, Ones DS, editors. Personality and Work Behaviors of Police Officers; Symposium conducted at the annual meeting of Society for Industrial and Organizational Psychology; Orlando, FL. 2003.
  26. Damos Diane L.Presentation to the Committee; August 10. 2009.
  27. Danzig Richard. Catastrophic Bioterrorism—What Is to Be Done? Washington, DC: Center for Technology and National Security Policy, National Defense University; 2003.
  28. Demmin Gretchen L. Biosurety. In: Lenhart Martha K., editor. Textbook of Military Medicine: Medical Aspects of Biological Warfare. Washington, DC: Borden Institute, Walter Reed Army Medical Center; 2007.
  29. Department of the Army. Nuclear and Chemical Weapons and Materiel: Biological Surety. Washington, DC: Department of the Army; 2008. Regulation 50–1.
  30. Department of State. UN Security Council Resolution 1540. 2009a. Available at < http://www​.state.gov/t/isn/c18943.htm>.
  31. Department of State. State Sponsors of Terrorism. 2009b. Available at < http://www​.state.gov/s/ct/c14151.htm>.
  32. DHB (Defense Health Board). Defense Health Board Task Force Review of the Department of Defense Biodefense Infrastructure and Biological Research Portfolio. Memorandum for the Surgeon General of the Army. Apr 29, 2009. Available at < http://www​.health.mil​/dhb/recommendations/2009/2009-01.pdf>.
  33. DOJ (Department of Justice). The Attorney General’s Report on Criminal History Background Checks. 2006. Available at < http://www​.usdoj.gov​/olp/ag_bgchecks_report.pdf>.
  34. DSB (Defense Science Board). Department of Defense Biological Safety and Surety Program. 2009. Available at < http://www​.acq.osd.mil​/dsb/reports/2009-05-Bio_Safety.pdf>.
  35. Ekboir Javier M. Potential Impact of Foot-and-Mouth Disease in California: The Role and Contribution of Animal Health Surveillance and Monitoring Services. Davis, CA: Agricultural Issues Center, Division of Agriculture and Natural Resources, University of California, Davis; 1999.
  36. FASEB (Federation of American Societies for Experimental Biology). FASEB Statement on Dual Use Research and Biosecurity Education. Mar 5, 2009. Available at < http://opa​.faseb.org​/pdf/2009/FASEB_Statement​_on_Dual_Use_Education.pdf>.
  37. FASEB and AAMC (Association of American Medical Colleges). Letter to U.S. Working Group on Strengthening the Biosecurity of the United States. May 29, 2006. 2009. Available at < http://opa​.faseb.org​/pdf/2009/Biosecurity_FASEB_AAMC_5​.29.09.pdf> and < http://www​.aamc.org/advocacy​/library/research​/corres/2009/052909.pdf>.
  38. FBI (Federal Bureau of Investigation). Science Briefing on the Anthrax Investigation: Opening Statement by Dr. Vahid Majidi. 2008. Available at < http://www​.fbi.gov/page2​/august08/anthraxscience_081808.html>.
  39. Fein Robert A, Vossekuil Bryan, Holden Gwen A. Threat Assessment: An Approach to Prevent Targeted Violence. Washington, DC: National Institute of Justice; 1995.
  40. Fein Robert A, Vossekuil Bryan.Presentation to the Committee; June 29. 2009.
  41. Fischer Julie E. Stewardship or Censorship? Balancing Biosecurity, the Public’s Health, and the Benefits of Scientific Openness. Washington, DC: The Henry L. Stimson Center; 2006.
  42. GAO (Government Accountability Office). Testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, U.S. House of Representatives. 2007. High-Containment Biosafety Laboratories: Preliminary Observations on the Oversight of the Proliferation of BSL-3 and BSL-4 Laboratories in the United States. GAO-08-108T.
  43. GAO. Biosafety Laboratories: Perimeter Security Assessment of the Nation’s Five BSL-4 Laboratories. Washington, DC: GAO; 2008. GAO-08-1092.
  44. GAO. Biosafety Laboratories: BSL-4 Laboratories Improved Perimeter Security Despite Limited Action by CDC. Washington, DC: GAO; 2009a. GAO-09-851.
  45. GAO. Personnel Security Clearances: An Outcome-Focused Strategy Is Needed to Guide Implementation of the Reformed Clearance Process. Washington, DC: GAO; 2009b. GAO-09-488.
  46. GAO. High-Containment Laboratories: National Strategy for Oversight Is Needed. Washington, DC: GAO; 2009c. GAO-09-574.
  47. George Alexander L, Bennett Andrew. Case Studies and Theory Development in the Social Sciences. Cambridge, MA: The MIT Press; 2005.
  48. Gottron Frank, Shea Dana. Oversight of High-Containment Biological Laboratories: Issues for Congress. Washington, DC: Congressional Research Service; 2009.
  49. Gronvall Gigi Kwik.Improving the Select Agent Program. Bulletin of the Atomic Scientists. 2008. Web Edition (October 29). Available at < http://www​.thebulletin​.org/web-edition/features​/improving-the-select-agent-program>.
  50. Hafer Nathaniel, Vos Cheryl J, McAllister Karen, Lorenzi Gretchen, Moore Christopher, Berger Kavita M, Stebbins Michael.How scientists view law enforcement. New survey of researchers tells us how to help the communities communicate. Science Progress. Dec 22, 2008. Available at < http://www​.scienceprogress​.org/2008/12/science-and-law-enforcement/>.
  51. Herbig Katherine L. Changes in Espionage by Americans: 1947–2007. Monterey, CA: Defense Personnel Security Research Center; 2008. Technical Report 08-5.
  52. Herbig Katherine L, Wiskoff Martin F. Espionage Against the United States by American Citizens 1947–2001. Monterey, CA: Defense Personnel Security Research Center; 2002. Technical Report 02-5.
  53. HHS (Department of Health and Human Services). “42 CFR 72 and 73 and 42 CFR Part 1003: Possession, Use, and Transfer of Select Agents and Toxins; Final Rule” (FR Doc. 05-5216). Federal Register. 2005 March 18;70(52):12294–13325. [PubMed: 15776528]
  54. HHS. 42 CFR Part 73: Possession, Use, and Transfer of Select Agents and Toxins; Proposed Addition of SARS-Associated Coronavirus (SARS-CoV). Federal Register. 2009a July 13;74(132):33401–33403.
  55. HHS. “42 CFR Part 73: Possession, Use, and Transfer of Select Agents and Toxins—Chapare virus.” (FR Doc. E9-19901). Federal Register. 2009b August 19;74(159):41829–41831.
  56. IOM (Institute of Medicine). To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 2000.
  57. IOM. Live Variola Virus: Considerations for Continuing Research. Washington, DC: National Academies Press; 2009.
  58. IOM/NRC (National Research Council). Effectiveness of National Biosurveillance Systems: BioWatch and the Public Health System: Interim Report. Washington, DC: National Academies Press; 2009. [PubMed: 25009937]
  59. Kelly Terrence K, Chalk Peter, Bonomo James, Jackson Brian A, Cecchine Gary.The Office of Science and Technology Policy Blue Ribbon Panel on the Threat of Biological Terrorism Directed Against Livestock: Conference Proceedings; Washington, DC. December 8–9, 2003; Arlington, VA: RAND Science and Technology; 2004.
  60. Kiehlbauch Julia A, Weyant Robbin S, Isaac Freeda, Firko Michael J.The Federal Select Agent Program. Presentation to the National Academies Committee on Scientific Milestones for the Development of a Gene-Sequence-Based Classification System for Oversight of Select Agents; September 3. 2009.
  61. LeDuc James W, Anderson Kevin, Bloom Marshall E, Carrion Ricardo Jr, Feldmann Heinz, Fitch J Patrick, Geisbert Joan B, Geisbert Thomas W, Holbrook Michael R, Jahrling Peter B, Ksiazek Thomas G, Patterson Jean, E. Rollin Pierre.Potential impact of a 2-person security rule on biosafety level 4 laboratory workers. Emerging Infectious Diseases Online Report. Jul, 2009. Available at < http://www​.cdc.gov/EID/content/15/7/e1​.htm>. [PMC free article: PMC5836487] [PubMed: 19624910]
  62. Leitenberg M. Assessing the Biological Weapons and Bioterrorism Threat. Carlisle Barracks, PA: Strategic Studies Institute, U.S. Army War College; 2005.
  63. Macrina Francis L. Scientific Integrity. 3rd ed. Washington, DC: ASM Press; 2005.
  64. Morgan Gareth. Images of Organization. Thousand Oaks, CA: Sage Publications; 1997.
  65. Murphy Kevin.Assessment Challenges. Presentation to the Committee; June 29. 2009.
  66. NAE (National Academy of Engineering). Ethics Education and Scientific and Engineering Research: What’s Been Learned? What Should Be Done? Summary of a Workshop. Washington, DC: National Academies Press; 2009.
  67. NELP (National Employment Law Project). A Scorecard on the Post-9/11 Port Worker Background Checks: Model Worker Protections Provide a Lifeline for People of Color, While Major TSA Delays Leave Thousands Jobless During the Recession. 2009. Available at < http://nelp​.3cdn.net​/2d5508b4cec6e13da6_upm6b20e5.pdf>.
  68. NIAID (National Institute of Allergy and Infectious Diseases). NIAID Strategic Plan for Biodefense Research, 2007 Update. Bethesda, MD: National Institutes of Health; 2007.
  69. NIAID. NIAID: Planning for the 21st Century, 2008 Update. Bethesda, MD: National Institutes of Health; 2008. NIH Publication No. 08-4753.
  70. NRC (National Research Council). The Polygraph and Lie Detection. Washington, DC: National Academies Press; 2003.
  71. NRC. Biotechnology Research in an Age of Terrorism. Washington, DC: National Academies Press; 2004a. [PubMed: 25057686]
  72. NRC. Seeking Security: Pathogens, Open Access, and Genomic Databases. Washington, DC: National Academies Press; 2004b. [PubMed: 25009887]
  73. NRC. Bridges to Independence: Fostering the Independence of New Investigators in Biomedical Research. Washington, DC: National Academies Press; 2005. [PubMed: 20669450]
  74. NRC. Globalization, Biotechnology, and the Future of the Life Sciences. Washington, DC: National Academies Press; 2006.
  75. NRC. Technical Input on the National Institutes of Health’s Draft Supplementary Risk Assessments and Site Suitability Analyses for the National Emerging Infectious Diseases Laboratory, Boston University: A Letter Report. Washington, DC: National Academies Press; 2007a.
  76. NRC. Science and Security in a Post 9/11 World: A Report on Regional Discussions between the Science and Security Communities. Washington, DC: National Academies Press; 2007b. [PubMed: 20669431]
  77. NRC. Department of Homeland Security Bioterrorism Risk Assessment: A Call for Change. Washington, DC: National Academies Press; 2008a.
  78. NRC. Emerging Cognitive Neuroscience and Related Technologies. Washington, DC: National Academies Press; 2008b. [PubMed: 25032330]
  79. NRC. Improving Democracy Assistance: Building Knowledge Through Evaluations and Research. Washington, DC: National Academies Press; 2008c.
  80. NRC. The 2nd International Forum on Biosecurity: Summary of an International Meeting; Budapest, Hungary. March 30 to April 2, 2008; Washington, DC: National Academies Press; 2009a.
  81. NRC. A Survey of Attitudes and Actions on Dual Use Research in the Life Sciences: A Collaborative Effort of the National Research Council and the American Association for the Advancement of Science. Washington, DC: National Academies Press; 2009b. [PubMed: 25009912]
  82. NRC. On Being a Scientist. 3rd ed. Washington, DC: National Academies Press; 2009c.
  83. NRC/IOM. Guidelines for Human Embryonic Stem Cell Research. Washington, DC: National Academies Press; 2005. [PubMed: 25009908]
  84. NRC/IOM. 2007 Amendments to the National Academies’ Guidelines for Human Embryonic Stem Cell Research. Washington, DC: National Academies Press; 2007. [PubMed: 25009908]
  85. NRC/IOM. 2008 Amendments to the National Academies’ Guidelines for Human Embryonic Stem Cell Research. Washington, DC: National Academies Press; 2008. [PubMed: 25009908]
  86. NSABB (National Science Advisory Board for Biosecurity). Proposed Framework for the Oversight of Dual Use Life Sciences Research: Strategies for Minimizing the Potential Misuse of Research Information. 2007. Available at < http://oba.od.nih.gov/biosecurity/pdf/Framework%20f or%20transmittal%200807_Sept07.pdf>.
  87. NSABB. Strategic Plan for Outreach and Education on Dual Use Research Issues. 2008. Available at < http://oba​.od.nih.gov​/biosecurity/PDF/FinalNSABBReportonOutreachandEducation-Dec102008.pdf>.
  88. NSABB. Enhancing Personnel Reliability among Individuals with Access to Select Agents. 2009. Available at < http://oba​.od.nih.gov​/biosecurity/meetings​/200905T/NSABB%20Final​%20Report%20on%20PR%205-29-09.pdf>.
  89. NSC (National Security Council). United States Policy on Chemical Warfare Program and Bacteriological/Biological Research Program. National Security Decision Memorandum 35. 1969. Available at < http://www​.state.gov​/documents/organization/90919.pdf>.
  90. OECD (Organisation for Economic Co-operation and Development). OECD Best Practice Guidelines on Biosecurity for BRCs (Biological Resource Centers). Paris: OECD; 2007. Available at < http://www​.oecd.org/dataoecd​/6/27/38778261.pdf>.
  91. Ostfield Marc L. Pathogen security: The illusion of security in foreign policy and biodefence. International Journal of Risk Assessment and Management. 2009;12(2–4):204–221.
  92. Pesenti Peter T.Presentation to National Academies Committee on Scientific Milestones for the Development of a Gene-Sequenced-Based Classification System for Oversight of Select Agents; September 3. 2009.
  93. Rowe Mary, Wilcox Linda, Gadlin Howard. Dealing with—or reporting—“unacceptable” behavior (with additional thoughts about the “Bystander Effect”). Journal of the International Ombudsman Association. 2009;2(1)
  94. Sackett Paul R, Harris Michael M. Honesty testing for personnel selection: A review and critique. Personnel Psychology. 1984;37:221–245.
  95. Sackett Paul R, Burris Laura R, Callahan Christine. Integrity testing for personnel selection: An update. Personnel Psychology. 1989;42:491–529.
  96. Sackett Paul R, Wanek James E. New developments in the use of measures of honesty, integrity, conscientiousness, dependability, trustworthiness, and reliability for personnel reliability. Personnel Psychology. 1996;49:787–829.
  97. Sackett Paul R, Lievens Filip. Personnel selection. Annual Review of Psychology. 2008;59:419–450. [PubMed: 17854285]
  98. Schein Edgar. Organizational culture and leadership. In: Shafritz Jay, Ott J Steven., editors. Classics of Organization Theory. Fort Worth, TX: Harcourt College Publishers; 2001.
  99. Schön DA. Beyond the Stable State: Public and Private Learning in a Changing Society. Harmondsworth: Penguin; 1973.
  100. Schulman Paul R, Roe Emory, van Eeten Michael, de Bruijne Mark. High reliability and the management of critical infrastructures. Journal of Crisis and Contingency Management. 2004;12(2):14–28.
  101. Senge Peter M. The Fifth Discipline: The Art and Practice of the Learning Organization. New York: Random House; 1990.
  102. Sheppard Blair H, Lewicki Roy J, Minton John W. Organizational Justice: The Search for Fairness in the Workplace. New York: Lexington Books; 1992.
  103. SIOP (Society for Industrial and Organizational Psychology). Principles for the Validation and Use of Personnel Selection Procedures. 4th ed. Bowling Green, OH: SIOP; 2003.
  104. SIOP. Types of Employment Tests. 2009a. Available at < http://www.siop.org/Workplace/employ ment%20testing/testtypes.aspx>.
  105. SIOP. How Many U.S. Companies Use Employment Tests? 2009b. Available at < http://www​.siop.org/Workplace​/employment%20testing​/usingoftests.aspx>.
  106. Stern Jessica Eve. Larry Wayne Harris (1998). In: Tucker Jonathan B., editor. Toxic Terror: Assessing Terrorist Use of Chemical and Biological Weapons. Cambridge, MA: MIT Press; 2000. pp. 227–245.
  107. Sutton Victoria. Survey finds biodefense anxiety—Over inadvertently violating regulations. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science. 2009;7(2):225–226. [PMC free article: PMC2995343] [PubMed: 19635007]
  108. Trans-Federal Task Force. Report of the Trans-Federal Task Force on Optimizing Biosafety and Biocontainment Oversight. Jul, 2009. Available at < http://www​.hhs.gov/aspr​/omsph/biosafetytask-force​/biosafetycontainmentrpt092009​.pdf>.
  109. Tucker Jonathan B., editor. Toxic Terror: Assessing Terrorist Use of Chemical and Biological Weapons. Cambridge, MA: MIT Press; 2000.
  110. Turner James T, Gelles Michael G. Threat Assessment: A Risk Management Approach. Binghamton, NY: The Haworth Press, Inc; 2003.
  111. UN (United Nations). Security Council Resolution 1540 (S/RES/1540). 2004. Available at < http://www​.state.gov/t/isn/73519.htm>.
  112. UN. Security Council Resolution 1810 (S/RES/1820). 2008. Available at < http://daccess-ods​.un​.org/access.nsf/Get?Open&DS=S​/RES​/1810%20(2008)&Lang​=E&Area=UNDOC>.
  113. USDA (U.S. Department of Agriculture). USDA Security Policies and Procedures for Biosafety Level-3 Facilities. 2002. Departmental Manual 9610-001. Available at < http://www​.ocio.usda​.gov/directives/doc/DM9610-001.htm>.
  114. USDA. “7 CFR Part 331 and 9 CFR Part 121: Agricultural Bioterrorism Protection Act of 2002; Possession, Use, and Transfer of Biological Agents and Toxins; Final Rule” (FR Doc. 05-5063). Federal Register. 2005 March 18;70(52):13242–13292.
  115. Washington Post. “Cocaine Justice” (editorial). 2009 July 16:A18.
  116. Weick Karl E, Sutcliffe Kathleen M. Managing the Unexpected: Assuring High Performance in an Age of Complexity. San Francisco, CA: Jossey-Bass; 2001.
  117. Weyant Robbin S.E-mail communication to the committee; August 6. 2009.
  118. Weyant Robbin S, Snyder Elizabeth.National Academies Briefing: Security Risk Assessments for Possession, Use, and Transfer of Select Agents. Presentation to the Committee; June 29. 2009.
  119. Wheelis Mark, Rózsa Lajos, Dando Malcolm., editors. Deadly Cultures: Biological Weapons Since 1945. Cambridge, MA: Harvard University Press; 2006.
  120. White House. Revised Adjudicative Guidelines for Determining Eligibility for Access to Classified Information. Memorandum for William Leonard. Dec 29, 2005. Available at < http://www​.fas.org/sgp/isoo/guidelines​.html>.
  121. White House. Reforming Processes Related to Suitability for Government Employment, Fitness for Contractor Employees, and Eligibility for Access to Classified National Security Information. Executive Order 13467. Jun 30, 2008. Available at < http://www​.fas.org/irp​/off-docs/eo/eo-13467.htm>.
  122. White House. “Strengthening Laboratory Biosecurity in the United States. Executive Order 13486 (January 9)” (FR Doc. E9-818). Federal Register. 2009 January 14;74(9):2289–2291.
  123. WHO (World Health Organization). Laboratory Biosafety Manual. 3rd ed. Geneva: WHO; 2004. WHO/CDS/CSR/LYO/2004.11. Available at < http://www​.who.int/entity​/csr/resources/publications​/biosafety/Biosafety7.pdf>.
  124. WHO. Biorisk Management: Laboratory Biosecurity Guidance. Geneva: WHO; 2006. WHO/CDS/EPR/2006.6.
  125. WHO. WHO recommendations concerning the distribution, handling, and synthesis of Variola virus DNA. 2008. Available at < http://www​.who.int/csr​/disease/smallpox/SummaryrecommendationsMay08.pdf>. [PubMed: 18975449]
  126. Wholey Joseph, Hatry Harry P, Newcomer Kathryn E., editors. Handbook of Practical Program Evaluation. 2nd ed. San Francisco, CA: Jossey-Bass; 2004.
  127. Wilkie Dana. Select-Agent Security Clearance Stymies Research. The Scientist. 2004 May 24;18(10):45.
  128. WMD Commission (Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism). World at Risk: The Report of the Commission on the Prevention of WMD Proliferation and Terrorism. New York: Vintage Books; 2008.
  129. World Bank. Monitoring and Evaluation: Some Tools and Approaches. Washington, DC: World Bank; 2004.
Copyright © 2009, National Academy of Sciences.
Bookshelf ID: NBK44950
Contents

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (934K)

Other titles in this collection

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...